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ABSTRACT  
The impact of R-loops on the physiology and pathology of chromosomes has been 
demonstrated extensively by chromatin biology research. The progress in this field has been 
driven by technological advancement of R-loop mapping methods that largely relied on a 
single approach, DNA-RNA immunoprecipitation (DRIP). Most of the DRIP protocols use the 
experimental design that was developed by a few laboratories, without paying attention to the 
potential caveats that might affect the outcome of RNA-DNA hybrid mapping. To assess the 
accuracy and utility of this technology, we pursued an analytical approach to estimate 
inherent biases and errors in the DRIP protocol. By performing DRIP-sequencing, qPCR and 
receiver operator characteristic (ROC) analysis, we tested the effect of formaldehyde fixation, 
cell lysis temperature, mode of genome fragmentation, and removal of free RNA on the 
efficacy of RNA-DNA hybrid detection, and implemented workflows that were able to 
distinguish complex and weak DRIP signals in a noisy background with high confidence. We 
also show that some of the workflows perform poorly and generate random answers. 
Furthermore, we found that the most commonly used genome fragmentation method 
(restriction enzyme digestion) led to the overrepresentation of lengthy DRIP fragments over 
coding ORFs, and this bias was enhanced at the first exons. Biased genome sampling 
severely compromised mapping resolution and prevented the assignment of precise 
biological function to a significant fraction of R-loops. The revised workflow presented herein 
is established and optimized using objective ROC analyses and provides reproducible and 
highly specific RNA-DNA hybrid detection. 
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INTRODUCTION 
R-loops are three stranded nucleic acid structures that are composed of an RNA-DNA hybrid 
and a displaced single-stranded DNA. Under physiological conditions R-loops are prevalent 
along the chromosomes, constituting 5-8% of the genome and impacting many cellular 
processes (Sanz et al. 2016; Wahba et al. 2016). For instance, R-loops i. drive embryonic 
stem cell differentiation via modulating the chromosomal binding of chromatin-regulatory 
complexes (Chen et al. 2015), ii. ensure the optimal binding of transcriptional activators to 
the promoter of the human vimentin (VIM) gene (Boque-Sastre et al. 2015), iii. massively 
form on estrogen-responsive genes in human breast and other tissues upon estrogen-
hormone stimulation (Stork et al. 2016a), iv. induce heterochromatin formation in 
Schizosaccharomyces pombe (Nakama et al. 2012), v. inhibit the expression of an antisense 
non-coding RNA in Arabidopsis thaliana, associated to the flowering process (Sun et al. 
2013). In a pathological context, perturbation or mutation of any of the following factors 
causes the chromosomal accumulation of RNA–DNA hybrids and consequent genomic 
instability: i. mRNA splicing factors and RNA export factors (e.g. THO2, HPR1, MFT1, THP2, 
THOC1-7, SRSF1) (Huertas and Aguilera 2003; Domínguez-Sánchez et al. 2011; Gan et al. 
2011; Li and Manley 2005), ii. RNA-DNA hybrid helicases (e.g. SETX / SEN1, AQR, PIF1) 
(Alzu et al. 2012; Mischo et al. 2011; Sollier et al. 2014; Boulé and Zakian 2007), iii. RNA-
DNA ribonucleases (RNASEH1 / RNH1, RNASEH2A-C / RNH201) (El Hage et al. 2010; 
Chon et al. 2013; Stuckey et al. 2015), iv. homologous recombination proteins (e.g. BRCA1, 
BRCA2, RTEL1, SRS2), (Hatchi et al. 2015; Bhatia et al. 2014), v. Fanconi anaemia proteins 
(FANCA, FANCB, FANCC)  (García-Rubio et al. 2015; Schwab et al. 2015), vi. 
topoisomerases (TOP1, TOP3B) (Wilson-Sali and Hsieh 2002; El Hage et al. 2010; Yang et 
al. 2014; Marinello et al. 2016) 
The above examples clearly illustrate the massive progress in the field that has been 
driven by technological advancements of R-loop detection methods. These techniques 
involve, for instance, electrophoretic mobility shift assays (Yu et al. 2006), atomic force 
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microscopy (Brown et al. 2008), transmission electron microscopy (Pohjoismäki et al. 2010), 
fluorescent microscopy (Székvölgyi et al. 2007), fluorescence in situ hybridization (Nadel et 
al. 2015), native bisulfite modification (Yu et al. 2003), immunoprecipitation (Skourti-Stathaki 
et al. 2011; Ginno et al. 2012b) and computational prediction (Jenjaroenpun et al. 2015). The 
increasing number of R-loop mapping data relied on a single approach, DNA-RNA 
immunoprecipitation (DRIP) and its variations (RDIP, DRIPc, S1-DRIP, DRIP-RNA, DIP, 
ChIP). The DRIP method applies the S9.6 anti-RNA-DNA hybrid antibody (Hu et al. 2006) to 
capture RNA-DNA hybrids in their native chromosomal context, followed by mapping the 
enriched DNA fragments on a selected number of loci or across the whole genome, using 
quantitative PCR, microarray hybridization or deep sequencing. 
Having surveyed the published RNA-DNA hybrid mapping studies (Chan et al. 2014; 
Ohle et al. 2016; Alzu et al. 2012; Cloutier et al. 2016; El Hage et al. 2010; Salvi et al. 2014; 
Sanz et al. 2016; Bhatia et al. 2014; Boque-Sastre et al. 2015; García-Rubio et al. 2015; 
Groh et al. 2014; Hatchi et al. 2015; Herrera-Moyano et al. 2014; Jenjaroenpun et al. 2015; 
Loomis et al. 2014; Pefanis et al. 2015; Rigby et al. 2014; Romanello et al. 2016; Skourti-
Stathaki et al. 2011; Sun et al. 2013; Yang et al. 2014; Zhang et al. 2014a, 2014b, 2015; 
Castellano-Pozo et al. 2013; Wahba and Koshland 2013; Yang et al. 2016; Mischo et al. 
2011; Chen et al. 2015; Ginno et al. 2012b; Lim et al. 2015; Stork et al. 2016b; Marinello et 
al. 2016; Nadel et al. 2015; Wahba et al. 2016; El Hage et al. 2014; Zeller et al. 2016) 
(Supplemental Table S1) we found that most DRIP protocols used the experimental design 
that was developed by a few laboratories (Supplemental Material, Figure S1). The original 
protocols are still being used without paying attention to their potential caveats: several 
critical points have remained exceedingly heterogeneous among the DRIP studies 
(Supplemental Table S1) that might account for at least some of the contradictory results 
(El Hage et al. 2014; Chan et al. 2014; Wahba et al. 2016; Nadel et al. 2015; Ginno et al. 
2012b). One can reveal technical heterogeneities i. in terms of the studied model organisms 
and cell types, ii. whether the cells were fixed by formaldehyde (HCHO) or not, iii. whether 
the immunoprecipitation was chromatin-based or DNA-based (ChIP vs. DIP), iv. in the cell 
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lysis temperature (65 °C, 55 °C, 37 °C), v. in the mode of DNA fragmentation (restriction 
enzyme digestion vs. sonication), vi. in total nucleic acid extraction (solid-phase purification 
vs. organic extraction, or salting out extraction), vii. in the application of ribonuclease A 
digestion to eliminate free RNA from the nucleic acid prep. Obviously, each of these 
variables can introduce substantial bias that might obscure the overall outcome of the 
experiment, but their consequence, alone or in combination, has remained unexplored. 
In the current study, we aimed to assess possible confounding effects related to key 
experimental variables of the DRIP procedure. Combining DRIP-qPCR, DRIP-sequencing 
and receiver operator characteristic (ROC) calculation, we devised an unbiased and 
systematic analytical pipeline in human T lymphoblastoid cells regarding the most important 
DRIP variables so that we suggest a reproducible and specific RNA-DNA hybrid detection, 
underlain by the objective criteria of ROC analysis. 
 
RESULTS 
Introducing DRIP classifiers to assess true and false R-loop associations 
Based on the available workflows of published DRIP protocols and considering the main 
technical variables that might contribute to the observed heterogeneities, we designed forty 
DRIP experimental schemes (binary classifiers) so that we assess how they rank different 
test loci according to their known RNA-DNA hybrid status (Fig. 1). The classifiers (“DRIP 
experiments” or “dependent variables”) were designed to systematically explore the main 
factors that might create experimental bias associated with the DRIP procedure. 
Experiments 1-16 considers the effect of i. formaldehyde (HCHO) fixation, ii. the method of 
nucleic acid isolation, iii. removal of free RNA, iv. the mode of nucleic acid fragmentation 
(Fig. 1A), and v. cell lysis temperature (65 °C as default vs. 37 °C; not shown in Fig. 1.A, but 
referred throughout the text as “37 °C”). 
Step 1: Formaldehyde fixation  
The basic assumption behind HCHO-crosslinking is to maximize the DRIP yield while 
preserving biologically meaningful RNA-DNA hybrid interactions. But formaldehyde has 
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some well-known adverse effects: i. the DNA accompanies a conformational change upon 
crosslinking, involving local denaturation or “breathing” of the double helix (McGhee and von 
Hippel 1977). This might create ectopic R-loop sites or abolish physiological R-loop contacts. 
ii. HCHO-treatment can reduce antigen accessibility or mask epitopes recognized by the 
antibody used for the immunoprecipitation. This might prevent a fraction of R-loops from 
being detected. iii. HCHO-fixation elicits spurious localization of irrelevant proteins at highly 
expressed genes (Baranello et al. 2016), and induces massive poly(ADP)ribose polymer 
formation in live cells (Beneke et al. 2012). These examples warrant deeper investigation of 
the usage of HCHO-fixation in RNA-DNA hybrid mapping, therefore we classified our DRIP 
samples as HCHO-treated and non-treated categories (Fig. 1A-B). 
Step 2: Nucleic acid purification 
Two common methods were compared: organic (phenol/chloroform) extraction versus solid-
phase (silica membrane) purification of total nucleic acids (Fig. 1A-B). 
Step 3: Ribonucleolytic treatment (RNase A, RNase H and sodium hydroxide) 
Most DRIP protocols do not treat the isolated nucleic acid with ribonucleases to remove free 
RNA, however the S9.6 antibody can recognize RNA duplexes with a ~5-fold reduced affinity 
compared to RNA-DNA hybrids (Phillips et al. 2013). At this point, four kinds of 
ribonucleoleolytic digestion were incorporated into our DRIP pipelines: i. RNase H1 digestion 
that removes RNA-DNA hybrids (negative control #1), ii. alkaline hydrolysis by sodium 
hydroxide that degrades free RNA and RNA-DNA hybrids (negative control #2), iii. RNase A 
digestion at high (300 mM) NaCl concentration that removes free RNA, iv. RNase A digestion 
at low (25 mM) NaCl concentration that removes free RNA and RNA-DNA hybrids.  
RNase H1 treatment is an accepted negative control of the DRIP procedure since it 
degrades the RNA strand in the hybrids preventing their recognition by the S9.6 antibody. 
Half of the nucleic acid prep was digested by RNase H1 before the DNA fragmentation step 
that made us estimate the bulk level of RNA-DNA hybrids (dot blot setting; Supplemental 
Material, Figure S2A). The other half was digested just before the S9.6 immunoprecipitation 
step that let us obtain crucial information about the specificity of the IP signal (see DRIP-
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qPCR). As expected, RNA-DNA hybrids were sensitive to RNase H1 digestion in vitro. 
Similarly to RNase H1, alkaline hydrolysis by 50 mM NaOH also efficiently eliminated the 
RNA-DNA hybrid signal (Supplemental Material, Figure S2A). Less is known about the 
salt-dependent RNase H-like activity of RNase A that is supposed to digest RNA-DNA 
hybrids as an efficient hybridase at low ionic strength 
(https://www.thermofisher.com/order/catalog/product/EN0531). As shown in Supplemental 
Figure S2B (Supplemental Material), the hybrids were indeed resistant to RNase A 
digestion at high ionic strength, but they became highly sensitive to RNase A as a function of 
decreasing monovalent concentration. The RNase H-like activity of RNase A at low salt 
condition was confirmed by an independent method (Supplemental Material, Figure S2C-
D) applying fluorescent microscopic detection. Based on these experiences, RNase A 
digestion at high salt concentration (300 mM NaCl) was integrated into our DRIP protocol to 
test if removal of competing free RNA improves the specificity of the RNA-DNA hybrid signal. 
Also, RNase H1 digestion of the fragmented nucleic acid was kept as an obligatory negative 
control of the immunoprecipitation. 
Step 4: Nucleic acid fragmentation 
The choice of restriction enzymes defines the cleavage pattern of DNA that is critical to 
achieve optimal fragment length distribution and mapping resolution. Based on the original 
DRIP protocol (Ginno et al. 2012b), we combined five enzymes (HindIII, EcoRI, BsrGI, XbaI 
and SspI) for in silico digestion, resulting in a median restriction fragment length of 314 bp 
(Supplemental Material, Figure S3A). In contrast to the theoretical fragment size 
distribution, we observed a broad DNA size range in a real digestion reaction (between 100-
10.000 bp; Supplemental Material, Figure S4A). As a control, we repeated the restriction 
enzyme cleavage in varying reaction conditions, without detecting any improvement in the 
digestion efficacy (Supplemental Material, Figure S3B). When a budding yeast genomic 
DNA was digested in a parallel experiment, we managed to obtain the expected (in silico) 
fragment size distribution (Supplemental Material, Figure S3C). These observations 
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necessitate for the proper control of DNA fragment length distribution in DRIP samples that 
derive from restriction enzyme fragmented nucleic acid. 
As opposed to restriction enzyme digestion, sonication creates random DNA fragments with 
a typical size of 150-500 bp that dictate the spatial resolution of the DRIP assay 
(Supplemental Material, Figure S4B). However, excessive sonication can introduce strand 
breaks in the DNA or simply shake off a subset of R-loops from the chromosomes, potentially 
compromising their detectability by qPCR. Because of the above, the mode of DNA 
fragmentation (restriction enzymes and sonication) was introduced as an important 
parameter in our DRIP pipeline (Fig. 1A). 
Fragmenting chromatin rather than purified genomic DNA (experiments 17-24) 
In comparison to the original DRIP protocol, classical chromatin immunoprecipitation (ChIP) 
involves the capture of RNA-DNA hybrids by immunoprecipitation from cross-linked and 
sonicated chromatin (rather than naked DNA) followed by phenol/chloroform purification (Fig. 
1C). Since sonication, performed on purified genomic DNA, led to loss of ∼80% of the DRIP 
signal in yeast (Wahba et al. 2016), we tested if acoustic shearing performed on a chromatin 
prep rather than on naked nucleic acid (Supplemental Material, Figure S4C) could improve 
the signal to noise ratio of the DRIP measurement (Fig. 1B). 
Varying the cell lysis temperature 
Published DRIP protocols apply various cell lysis temperatures, ranging from 37 °C to 65 °C 
and lasting from a couple of hours to overnight. To test the effect of temperature on the 
specificity of RNA-DNA hybrid detection, we lysed the samples at 65 °C for 7 hrs, or at 37 °C 
overnight. Experiments 1-16 were processed in parallel at both temperatures, while exp. 17-
24 were omitted from the temperature analysis since crosslink reversal typically occurs at 65 
°C. 
Taken together, the above experimental variables resulted in forty (16x2+8) autonomous 
DRIP classifiers (schemes) for which RNA-DNA hybrid enrichment scores were determined 
at several test loci. This allowed us to assess whether the S9.6 signal represented true or 
false R-loop associations within the applied condition. 
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Making a reference R-loop set for benchmarking the DRIP classifiers  
To derive the parameters of the DRIP classifiers, known positive and negative examples 
(genomic sites) could be chosen from the scientific literature based on their known R-loop 
profiles; however, the heterogeneity of the available DRIP-qPCR and DRIP-seq datasets 
(see Introduction) prompted us to establish our independent R-loop training set. We 
performed DNA-RNA hybrid mapping (DRIP-seq) in two closely related human cell types 
(Jurkat T cell leukemia cell line and naive CD4+ T lymphocytes) and identified 88.830 and 
99.337 R-loop enriched regions, respectively (Fig. 2A). A high-confidence R-loop peak set 
was generated from the identified binding sites and their chromosomal distribution was 
characterized. The peaks were significantly enriched at gene promoters and repetitive 
elements (Fig. 2B), consistent with previously published DRIP-seq results (Ginno et al. 
2012a; Nadel et al. 2015). R-loop sites were underrepresented at protein coding exons, 
similarly to earlier DRIP experiments performed with sonicated nucleic acid, however 
restriction enzyme fragmented DRIP samples were positively biased towards exons. 
Sonicated and restriction enzyme digested samples were strikingly different in their R-loop 
length distributions (narrow: 179-2.369 bp vs. wide: 178-22.479 bp; Fig. 2C), and the 
identified R-loop binding sites significantly overlapped within each group, but sharply stood 
apart between the two groups (Fig. 2D). We attribute these differences to the extensive 
variation of R-loop lengths and heterogeneities of the studied cell types. Biological 
implications of having too wide peak sizes will be discussed later. With the observed 
variances in mind, our consensus R-loop set was regarded as an amenable reference to 
benchmark the DRIP classifiers. 
 
Measuring RNA-DNA hybrid enrichment over the DRIP classifiers 
Positive and negative test regions were selected from the identified R-loop set 
(Supplemental Material, Figure S5) and were systematically probed for RNA-DNA hybrid 
enrichment across the DRIP classifiers (Supplemental Material, Figure S6). Five test 
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regions were frequently used as positive and negative controls in various published DRIP 
studies (SNRPN, ZNF554, MYADM, FMR1, APOE; (Yang et al. 2014; Marinello et al. 2016; 
Groh et al. 2014; García-Rubio et al. 2015; Loomis et al. 2014; Bhatia et al. 2014; Herrera-
Moyano et al. 2014; Ginno et al. 2012b; Boque-Sastre et al. 2015), while the remaining sites 
were picked at random from the consensus R-loop set (PRR5L, LOC440704, NOP58, VIM, 
ING3). The reference DRIP-seq signal (benchmarking the classifiers) is shown over selected 
test regions along with DRIP-seq patterns taken from published studies (Supplemental 
Material, Figure S5). DRIP-qPCR yields were measured in control and RNase H-treated 
samples for forty (16x2+8) DRIP classifiers, at ten test regions, in five independent 
experiments. The resulting 4000 (40x2x10x5) DRIP enrichment scores were then readily 
used as an input parameter of receiver operator characteristics (ROC) calculation. 
 
Determining the sensitivity and specificity of RNA-DNA hybrid detection: ROC 
analysis  
We quantitated the relative trade-offs between true positive hits and experimental errors 
(false R-loop associations) by performing ROC analysis (Robin et al. 2011) on the DRIP-
qPCR screen characterizing the classifiers (Supplemental Material, Figures S6-S10). The 
sensitivity, specificity and the area under the curve (AUC) values were extracted from the 
ROC plots (Supplemental Table S2) and used as an objective measure of the robustness of 
the forty experiments. High (>0.7) AUC values were obtained for ten DRIP classifiers (exp. 5, 
6, 13, 15, 17, 18, 19, 21, and 24), implying that those experiments could predict the presence 
or absence of an RNA-DNA hybrid with high efficacy (Fig. 3A). AUC values close to 0.5 were 
obtained in four experiments (exp. 2, 10, 11, and 16), implying that the classifiers gave 
random answers without any predictive power as to the presence of an R-loop. Based on 
these considerations, the top four DRIP classifiers were: exp. 5, 13, 17, and 19 (Fig. 3B-C) 
with a sensitivity of 68.5-75 % and specificity of 68-79 %. Similar (or even higher) ROC 
parameters were obtained in a repeated experiment using a B lymphoblastoid cell line 
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(Supplemental Material, Figure S8), demonstrating the reliability of the tested DRIP 
protocols in other cell types. 
Pairwise comparison of the main experimental variables (Fig. 3D) revealed no significant 
difference between i. formaldehyde-fixed vs. unfixed samples, ii. phenol-chloroform extracted 
vs. silica membrane purified nucleic acid samples, and iii. DNA-fragmented (exp. 1-16) vs. 
chromatin-fragmented DRIP samples (exp. 17-24). Cell lysis temperature (65°C vs. 37°C) did 
not change the specificity and sensitivity of the DRIP assay (Supplemental Material, 
Figures S9-S10). Statistically significant difference was obtained for RNase A-treated vs. 
untreated samples (p=0.03), suggesting that addition of RNase A does not improve the 
efficacy of RNA-DNA hybrid detection (Step 3, Fig. 3D). We explain the adverse effect of 
RNase A by its reported DNA binding activity (Benore-Parsons and Ayoub 1997; Dona and 
Houseley 2014) that selectively eliminates a vast amount (micrograms) of melted DNA 
regions upon nucleic acid purification (Dona and Houseley 2014). We confirmed the strong 
DNA binding of RNase A as migration defects on DNA gels, when a plasmid DNA was 
incubated with the enzyme (Supplemental Material, Figures S11). The observed 
electrophoretic mobility shift was prevalent on supercoiled, nicked-circular and linearized 
DNA templates. 
Finally, by comparing sonicated and restriction enzyme fragmented DRIP samples (Step 4, 
Fig. 3D) we found a statistically significant difference (p=0.0002) in the ROC parameters, 
suggesting that sonication in more efficient in discriminating true positive signals from false 
positives, at least within the tested conditions. 
 
Good DRIP practice: impact on the annotation and basic biological function of R-loops 
Suboptimal DRIP conditions might prevent the assignment of precise biological function to a 
significant fraction of R-loops. Although the average DNA fragment size resulting from 
restriction enzyme digestion fits the requirements of the DRIP assay, we found that the 
frequency of cutting sites was significantly higher within intergenic regions, producing lengthy 
restriction fragments over protein coding ORFs (Fig. 4). Biased genome sampling, related to 
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the non-random distribution of restriction enzyme recognition sequences, was even more 
pronounced over exons (Fig. 4C), especially over the first exons (Fig. 4D). In 82% of first 
exons there were only 0-1 suitable restriction sites compared to intergenic regions (59%). We 
estimated the digestion efficiency of restriction enzyme cutting sites to ~50 % over intergenic 
regions (based on the proportion of zero reads over restriction enzyme cutting sequences, 
representing cleaved sites), which was significantly reduced over gene coding regions (Fig. 
4E-F). Consequently, genic regions void of suitable restriction sites appear as long DRIP 
fragments that potentially compromise mapping resolution. The MYC, BCL6, and VIM genes 
are shown as representative examples for large, restriction fragment-sized DRIP peaks (Fig. 
5). Precise genomic position of R-loops could be resolved by sonication. 
 
DISCUSSION  
The increasing recognition of RNA-DNA hybrid structures in the physiology and pathology of 
chromosomes has prompted us to develop an analytical approach to estimate the inherent 
biases and errors of existing DRIP protocols and to assess the power of the technology. The 
determined ROC parameters (AUC, sensitivity, specificity, threshold) served as an objective 
measure for the efficacy of predicting the presence or absence of RNA-DNA hybrids. In the 
tested experimental conditions, we managed to find and verify DRIP workflows that were 
able to distinguish complex or weak DRIP-qPCR signals from a noisy background with high 
confidence across a number of genomic regions (exp. 5, 13, 17, and 19). On the contrary, 
some DRIP workflows performed unreliably and generated random answers (exp. 2, 10, 11, 
and 16). Under our experimental conditions, we highlight these groups as “preferred” and 
“not preferred”. By testing the main parameters of the DRIP experimental scheme - involving 
formaldehyde fixation, cell lysis temperature, nucleic acid isolation, free RNA removal, and 
DNA fragmentation – we found that fragmenting the nucleic acid by sonication and omitting 
RNase A digestion could improve the precision and specificity of RNA-DNA hybrid detection 
(Fig. 3D). At this point we emphasize the lack of correlation between the DRIP scores 
(IP/input ratios) and AUC values, as these quantities are not related to each other. The 
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former highlights the yield of immunoprecipitation, while the latter is a quantitative measure 
of true and false R-loop associations. For instance, the worse and best DRIP schemes (exp 
2 and exp 5) had a qPCR yield of 10%-95% and 1%-18% over the studied regions, 
respectively (Supplemental Material, Figures S6 and S8). Consequently, high DRIP 
enrichment does not necessarily accompany with increased accuracy, and vice versa. 
We also showed that genome fragmentation by restriction enzymes led to the 
overrepresentation of long DRIP fragments over ORFs, which was especially enhanced over 
the first exons of protein coding genes (Figs. 4-5). Biased genome sampling severely 
compromised mapping resolution and, as a consequence, the assignment of clear biological 
function to a fraction of R-loops. For instance, correct estimation of evolutionary conservation 
between R-loop binding sites, relying on sequence homologies of exons that are associated 
with R-loops (Sanz et al. 2016), becomes uncertain. 
Based on the above experiences, we suggest the following refinements of DRIP workflows to 
obtain accurate estimates of RNA-DNA hybrid occupancies: 1. Omission of HCHO-fixation 
and RNase A treatment, isolation of nucleic acid by silica membrane (kit) purification, nucleic 
acid fragmentation by sonication, followed by immunoprecipitation with the S9.6 antibody 
(see Methods). 2. If formaldehyde-fixation is applied, we recommend preparing soluble 
chromatin and fragmenting the prep by sonication (similarly to the ChIP protocol), followed by 
organic extraction and immunoprecipitation with the S9.6 antibody. 3. If restriction enzyme 
fragmentation needs to be applied (e.g. in some cases sonication might be too harsh to 
capture transient or very week RNA-DNA hybrid interactions), we advise the careful control 
of DNA fragment size distribution before immunoprecipitation. 
An important premise is that our recommendations apply to the experimental conditions 
investigated by this study. Generalization should be avoided since altering critical parameters 
in the experiment (e.g. incorporating S1 nuclease (S1-DRIP) (Wahba et al. 2016) or lambda 
exonuclease digestion (DRIP-exo) (Ohle et al. 2016), or changing the model organism) might 
significantly affect the outcome of RNA-DNA hybrid detection. 
14 
 
In conclusion, the DRIP method remains a gold-standard for identifying bona fide R-loop 
binding sites across individual chromosomes, but a continued effort is needed to find 
alternatives and test complementary protocols. We hope that this aim has been achieved, at 
least in part, by this study that will help recognize real R-loop binding events and enable a 
better interpretation of DRIP-seq mapping data. 
 
METHODS 
Detection of RNA-DNA hybrids by DNA-RNA immunoprecipitation (DRIP) 
I. DRIP classifiers 1-16 
Crosslinking (Step 1) 
Crosslinking of Jurkat cells (experiments 1-8) was done with 1% paraformaldehyde (UP) for 
10 minutes, then quenched with 2.5 M glycine (pH 6, final concentration: 500 mM) for 5 
minutes at room temperature. Crosslinking was omitted from experiments 9-16. 
Cell lysis 
Cells were lysed in 1 ml lysis buffer composed of 500 µl 2x lysis buffer (1% SDS, 20 mM 
Tris-HCl pH 7.5, 40 mM EDTA pH 8, 100 mM NaCl, ddH2O) plus 500 µl TE buffer (100 mM 
Tris-HCl pH 8, 10 mM EDTA pH 8) per 5 million cells. Cell lysis was performed at two 
different temperatures: either at 65 °C for 7 hours, or at 37 °C overnight, as indicated in the 
text.  
Phenol chloroform extraction of total nucleic acid (Step 2) 
In experiments 1-4, and 9-12, total nucleic acid was prepared by phenol-chloroform 
extraction. Before the phenol-chloroform extraction step, the nucleic acid preps were treated 
with 10 µl of Proteinase K (20 mg/ml; Thermo Fisher Scientific) at 65 °C for 7 hours, or at 37 
°C overnight, to remove the proteins. The extracted DNA was precipitated with 1/10 volume 3 
M Na-acetate (pH 5.2) plus 1 volume of isopropanol. The DNA pellet was dissolved in 200 µl 
of 10 mM Tris-HCl pH 8.  
Silica membrane-based (kit) extraction of total nucleic acid (Step 2) 
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In experiments 5-8 and 13-16, total nucleic acid was isolated by the NucleoSpin Tissue Kit 
(Macherey-Nagel) according to the manufacturer’s protocol, except the cell lysis step that 
was performed either at 65 °C for 7 hours (according to the kit protocol), or at 37 °C 
overnight, where indicated in the text. Nucleic acids were eluted in 500 µl of elution buffer (5 
mM Tris-HCl pH 8.5).  
Removal of free RNA by RNase A treatment (Step 3) 
In experiments 3-4, 7-8, 11-12, and 15-16, the DNA purification step was directly followed by 
the RNase A digestion of free ribonucleic acids. The purified DNA preps (from Step 2) were 
supplemented with 18 µl of 5 M NaCl and 2 µl of RNase A (10 mg/ml; UD-GenoMed Ltd.) in a 
buffer containing 10 mM Tris-HCl (pH 8) and 300 mM NaCl (V=300 µl) at 37 °C for 1 hour. 
RNase A-treated samples were re-purified either by phenol-chloroform extraction 
(experiments 4, 12) or by the NucleoSpin Gel and PCR Clean-up Kit (Macherey-Nagel) 
(experiments 8, 16). Phenol-chloroform extracted DNA was dissolved in 100 μl of 5 mM Tris-
HCl pH 8.5. The DNA purified with the kit was eluted in 5 mM Tris-HCl pH 8.5.  
Nucleic acid fragmentation by sonication (Step 4) 
In experiments 1, 3, 5, 7, 9, 11, 13, 15, the purified nucleic acid preps were sonicated in a 
buffer of 10 mM Tris-HCl pH 8.5 supplemented with 300 mM NaCl (V=300 μl) for 2 x 5 min 
(30 sec ON, 30 sec OFF, LOW; Bioruptor, Diagenode) to yield an average DNA fragment 
size of ∼300 bp.  
Nucleic acid fragmentation by restriction enzyme digestion (Step 4) 
In exp. 2, 4, 6, 8, 10, 12, 14, 16, purified DNA samples (∼25 μg each) were fragmented using 
a restriction enzyme cocktail of 1 μl HindIII (20 U/μl), 1 μl EcoRI (20 U/μl), 2 μl BsrGI (10 
U/μl), 1 μl XbaI (20 U/μl), 4 μl SspI (5 U/μl)) in NEB Buffer 2 (NEB) (V=300 μl) at 37 °C, for 4 
hours. 
The fragmented DNA samples were re-purified either by phenol-chloroform extraction 
(experiments 1-4; 9-12) or by the NucleoSpin Gel and PCR Clean-up Kit (Macherey-Nagel) 
(experiments 5-8; 13-16). The DNA was dissolved in 100 μl of 5 mM Tris-HCl pH 8.5.  
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Two percent (V/V%) of the DNA preps were kept as input DNA for the DRIP-qPCR 
measurement. Half of samples were treated by 8 μl of RNase H (5000 U/ml; NEB) in a total 
volume of 80 μl, at 37 °C, overnight.  
II. DRIP classifiers 17-24 
Crosslinking (Step 1) 
Crosslinking of Jurkat cells (experiments 17-20) was done with 1% paraformaldehyde (UP) 
for 10 minutes, then quenched with 2.5 M glycine (pH 6, final concentration: 500 mM) for 5 
minutes at room temperature. Crosslinking was omitted from experiments 21-24. 
Chromatin preparation (Step 2) 
Cell lysis 
Cells were lysed 750 µl of ChIP lysis buffer (50 mM HEPES-KOH at pH 7.5, 140 mM NaCl, 1 
mM EDTA at pH 8, 1% Triton X-100, 0.1% Na-Deoxycholate, 1% SDS) per 10 million cells 
and homogenized using Fast Prep-24 5G (MP Biomedicals, speed: 6 m/s; time: 40 sec; 2 
cycles; pause time: 120 sec; A lysing matrix). 
Chromatin fragmentation by sonication (Step 3) 
300 μl of chromatin preps were sonicated for 2 x 5 min (30 sec ON, 30 sec OFF, LOW, 
Bioruptor) to yield an average DNA fragment size of ∼300 bp. 
Removal of free RNA by RNase A treatment (Step 4) 
In experiments 19, 20, 23, 24, the sonication step was directly followed by the RNase A 
digestion of free ribonucleic acids. The fragmented chromatin was supplemented with 270 µl 
of 5 M NaCl (300 mM) and 10 µl of RNase A (10 mg/ml; UD-GenoMed Ltd.) in 4500 µl of TE 
buffer (10 mM Tris-HCl pH 8, 10 mM EDTA pH 8) at 37 °C for 1 hour.  
Before Step 5, the chromatin preps were treated with 30 µl of Proteinase K (20 mg/ml; 
Thermo Fisher Scientific) at 65 °C overnight to remove the proteins and reverse the cross-
links. 
Phenol chloroform extraction of total nucleic acid (Step 5) 
In experiments 17, 19, 21, 23, total nucleic acid was prepared by phenol-chloroform 
extraction. The extracted DNA was precipitated with 1/10 volume 3 M Na-acetate (pH 5.2) 
17 
 
plus 1 volume of isopropanol. The DNA pellet was dissolved in 100 µl of 5 mM Tris-HCl pH 
8.5.  
Silica membrane-based (kit) extraction of total nucleic acid (Step 5) 
In experiments 18, 20, 22, 24, total nucleic acids were isolated by the NucleoSpin Gel and 
PCR Clean-up Kit (Macherey-Nagel) according to the manufacturer’s protocol. Nucleic acids 
were eluted in 100 μl of elution buffer (5 mM Tris-HCl pH 8.5). 
Two percent (V/V%) of the DNA preps were kept as input DNA for the DRIP-qPCR 
measurement. Half of samples were treated by 8 μl of RNase H (5000 U/ml; NEB) in a total 
volume of 80 μl, at 37 °C, overnight. 
III. RNA-DNA hybrid Immunoprecipitation with the S9.6 antibody 
Dynabeads Protein A magnetic beads (ThermoFisher Scientific) were pre-blocked with 
PBS/EDTA containing 0.5% BSA. To immobilize the S9.6 antibody, 50 µl pre-blocked 
Dynabeads Protein A was incubated with 10 μg of S9.6 antibody in IP buffer (50 mM 
Hepes/KOH at pH 7,5; 0,14 M NaCl; 5 mM EDTA; 1% Triton X-100; 0,1 % Na-Deoxycholate, 
ddH2O) at 4°C for 4 hours with rotation. Six micrograms of digested genomic DNA was 
added to the mixture and gently rotated at 4°C, overnight. Beads were recovered and 
washed successively with 1ml lysis buffer (low salt, 50 mM Hepes/KOH pH 7.5, 0.14 M NaCl, 
5 mM EDTA pH 8, 1% Triton X-100, 0.1 % Na-Deoxycholate), 1ml lysis buffer (high salt, 50 
mM Hepes/KOH pH 7.5, 0.5 M NaCl, 5 mM EDTA pH 8, 1% Triton X-100, 0.1 % Na-
Deoxycholate), 1ml wash buffer (10 mM Tris-HCl pH 8, 0.25M LiCl, 0.5% NP-40, 0.5%  Na-
Deoxycholate, 1 mM EDTA pH 8) and 1ml TE (100 mM Tris-HCl pH 8, 10 mM EDTA pH 8) at 
4°C, two times. Elution was performed in 100 μl of elution buffer (50 mM Tris-HCl pH 8, 10 
mM EDTA, 1 % SDS) for 15 min at 65 ˚C. After purification by NucleoSpin Gel and PCR 
Clean-up Kit (Macherey-Nagel), nucleic acids were eluted in 55 µl of elution buffer (5 mM 
Tris-HCl pH 8.5). The recovered DNA was then analyzed by quantitative real-time PCR 
(qPCR). qPCR was performed with LightCycler 480 SYBR Green I Master (Roche) and 
analyzed on QuantStudio 12K Flex Real-Time PCR System (Thermo Fisher Scientific). 
Primer sequences are listed on Supplemental Table S3. qPCR results were analyzed using 
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the comparative CT method. The RNA-DNA hybrid enrichment was calculated based on the 
IP/Input ratio. 
 
DRIP-sequencing 
DRIP-sequencing was performed in human Jurkat cells and naive T CD4+ lymphocytes. Full 
description of the DRIP-seq experiment and bioinformatics analysis can be found in the 
Supplemental Material.  
 
Receiver Operating Characteristic (ROC) Analysis 
ROC curves were obtained for each DRIP variables (DRIP experiments) by ranking the 
studied genomic loci having known RNA-DNA hybrid states (based on the training set) 
according to their DRIP-qPCR profile, starting from the lowest to the highest estimated DRIP 
scores and then calculating sensitivity and specificity. The ROC curves plotted the sensitivity 
or true positive rate (TPR) against the false-positive rate (FPR) or 1-specificity, estimated as 
follows: TPR = P(positive DRIP-qPCR result | R-loop present), FPR = P(positive DRIP-qPCR 
result | R-loop absent), where P means conditional probability. The AUC values were then 
calculated from the observed DRIP-qPCR (IP/input) yields using the pROC algorithm. 
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FIGURE LEGENDS 
Figure 1. Experimental Design: Constructing DRIP Schemes.  
(A) Experiments 1-16 explore the effect of formaldehyde-fixation (Step 1), nucleic acid 
isolation (Step 2), removal of free RNA (Step 3), and nucleic acid fragmentation (Step 4) on 
the outcome of RNA-DNA hybrid detection. Each experiment was performed at two parallel 
cell lysis temperatures (65°C and 37°C), respectively. The temperature variable is not 
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depicted in the cartoon, but it is referred in the main text. (B) Experiments 17-24 test the 
impact of acoustic sharing performed on a chromatin prep rather than on naked nucleic acid, 
similarly to the ChIP protocol. Each experiment was performed at 65°C cell lysis 
temperature. (C) Workflow of a ChIP experiment (shown only for comparison with the DRIP 
pipeline). Abbreviations: HCHO: Formaldehyde fixation; Phe/Chl: Phenol/Chloroform 
extraction; Kit: silica membrane-based nucleic acid purification; RNase A: Ribonuclease A 
digestion performed at high (300 mM) NaCl concentration. Son: Sonication; RE: restriction 
enzyme cocktail digestion (HindIII, EcoRI, BsrGI, XbaI and SspI). As a negative control, 
RNase H digestion was applied in all DRIP experiments (not indicated in the cartoon). 
 
Figure 2. Summary of Available Human DRIP-seq Experiments. 
(A) Bar chart showing the number of identified R-loop peaks in human Jurkat cells and naive 
T cells (this study). (B) Annotation of R-loop binding sites over functional genomic elements. 
DRIP-seq peaks were determined in Jurkat cells and naive T cells, and in other published 
cell types (NTERA2, K562, Fibroblast, MCF7, IMR90, HEK293T). The upper four rows 
represent DRIP experiments fragmenting the nucleic acid by sonication, while the lower five 
rows highlight restriction enzyme-digested DRIP samples. The difference between the two 
groups is especially noticeable over exons (associated to 14%-27% and 1%-3.5% of R-
loops, respectively) and repeat elements (SINEs, LINEs, LTRs, simple and low complexity 
repeats) that involve 22%-38% and 54%-67% of the R-loop peaks, respectively. At other 
annotation categories (gene body, introns and promoters) the difference was not significant 
between the two groups. (C) Density plots showing the distribution of R-loop peaks sizes, 
classified by fragmentation method (restriction enzyme vs. sonication). Median peak length 
and 2.5%-97.5% quantiles are indicated. Peak length distributions differ significantly between 
the two fragmentation methods. (D) Heatmap showing the overlap of R-loop binding sites 
between independent DRIP-seq experiments. Values and cell colors represent pairwise and 
unique overlap ratios between each peak set. The difference between the two nucleic acid 
27 
 
fragmentation methods is clearly apparent, as peak sets from the same fragmentation 
process better resemble to each other (highlighted in black). 
 
Figure 3. Good DRIP Practice. 
(A) Bar charts showing the distribution of AUC (area under the curve) values of ROC plots for 
twenty-four DRIP classifiers. Error bars represent the confidence interval of AUCs. High 
(>0.7) AUC values were obtained for ten DRIP classifiers (exp. 5, 6, 13, 15, 17, 18, 19, 21, 
and 24). Low (~0.5) AUC values were obtained in four DRIP experiments (exp. 2, 10, 11, and 
16). We highlight these groups as “preferred” and “not preferred”, respectively. (B-C) The top 
four DRIP experiments ranked by AUCs (exp 5, 13, 17, 19). (B) DRIP-qPCR enrichment 
scores are displayed over the test regions. Horizontal dotted lines represent the cutoff value 
(calculated from the ROC curves) separating the true R-loop signal from background. (C) 
ROC curves of the top four experiments. (D) Paired-ROC plots, comparing the main 
variables (steps) of the DRIP experiments. The level of statistical significance was 0.05. 
 
 
Figure 4. Analysis of restriction sites over genic and intergenic regions.  
(A) Restriction fragment lengths over genic regions (gene bodies, exons, first exons) are 
significantly larger compared to intergenic regions. The plot shows the difference of genic 
(observed) and intergenic (expected) fragment sizes in base pairs. The following enzymes 
were applied in combination: HindIII, EcoRI, BsrGI, XbaI and SspI. (B-C-D) The number of 
restriction sites over genic regions is significantly lower compared to intergenic regions. 
Colors indicate the proportion of cutting sites in each category. Red and blue slices, marking 
the rarest restriction site frequencies, are prevalent over genic elements in each pie chart. 
(E) Cutting efficiency of restriction enzymes applied in the indicated DRIP-seq experiments. 
Zero read: the restriction site was cut. Greater equal than one read: the restriction site was 
uncut in a fraction of cells. There were uncut reads (sites) over half of the theoretical 
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restriction sites. The proportion of uncut reads was even higher within gene coding regions 
compared to intergenic regions. See the model of cutting efficiency in panel (F). 
 
Figure 5. Large restriction fragments over gene bodies causes uncertainty in the precise 
localization of R-loops, potentially impeding their functional annotation. 
(A-C) Genome browser tracks showing three representative examples (MYC, BCL6 and 
VIM). Upper two tracks: restriction fragment-sized R-loops are prevalent over the 5’ prime 
end of genes, vastly exceeding the gene borders in the case of MYC. Lower two tracks: the 
precise genomic position of R-loops was resolved in the sonicated group of samples. Green 
boxes represent R-loop enriched regions predicted by the peak callers. Blue dashed lines 
represent cutting sites for restriction enzymes (HindIII, EcoRI, BsrGI, XbaI and SspI). 
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